Skip to main content
. 2020 Aug 18;11(1):1797306. doi: 10.1080/20008198.2020.1797306

Table 1.

Unadjusted means (SD) for outcomes by treatment group and time point.

  Baseline
6-month
12-month
  SE+Phys
(n = 55)
Phys
(n = 59)
SE+Phys
(n = 45)
Phys
(n = 46)
SE+Phys
(n = 49)
Phys
(n = 49)
Primary outcome            
RMDQ (0–100) 64.22 (19.02) 68.90 (19.32) 47.00 (26.96) 53.67 (26.16) 51.11 (28.00) 50.17 (27.04)
Secondary outcomes            
HTQ (0–48) 23.81 (7.15) 26.28 (6.49) 21.35 (10.90) 23.12 (9.01) 21.20 (10.78) 21.52 (11.06)
NRS (0–10) 6.33 (2.11) 6.33 (1.80) 4.27 (2.54) 4.39 (2.07) 4.61 (2.51) 4.69 (2.52)
TSK (17–68) 45.65 (5.45) 46.16 (4.82) 41.15 (6.30) 42.81 (6.01) 41.56 (6.23) 42.05 (5.89)
PCS (0–52) 27.24 (8.47) 26.76 (8.69) 18.08 (10.64) 18.70 (9.42) 19.11 (12.11) 19.83 (10.77)
HADS-D (0–21) 7.51 (3.86) 7.83 (3.27) 7.44 (5.09) 6.55 (4.26) 6.77 (4.62) 6.69 (4.27)
HADS-A (0–21) 10.12 (3.15) 9.58 (3.77) 9.05 (4.76) 8.12 (4.26) 9.55 (4.57) 8.63 (4.12)

n = the number of participants with primary outcome data at each time point. RMDQ = Roland Morris Disability Questionnaire; HTQ = Harvard Trauma Questionnaire; NRS = Mean pain intensity on a Numerical Rating Scale; PCS = Pain Catastrophising Scale; HADS-D/A = Hospital Anxiety and Depression Scale;

SE = Somatic Experiencing®; Phys = Physiotherapy.